Table 4.
Antioxidant Results (Mean ± SD) of Study Groups at Baseline and Endpoint
| Variable | Group | Baseline | Endpoint | MD | 95%CI | Sig (p) | MD | 95%CI | Sig (p) | MD | 95%CI | Sig (p) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDA (nmol/mL) | CG | 1.62 ± 0.28 | 1.54 ± 0.17 | |||||||||
| ZG | 1.65 ± 0.45 | 1.16 ± 0.21 | −0.18 | −0.40 to 0.05 | 0.203 | |||||||
| RTG | 1.56 ± 0.44 | 1.08 ± 0.19 | −0.26 | −0.49 to −0.04 | 0.013 | −0.08 | −0.31 to 0.14 | 1 | ||||
| ZRTG | 1.54 ± 0.22 | 0.87 ± 0.14 | −0.38 | −0.60 to −0.15 | 0.000 | −0.20 | −0.42 to 0.02 | 0.110 | −0.12 | −0.34 to 0.11 | 1 | |
| GSH (mg/mL) | CG | 237 ± 23 | 230 ± 24 | |||||||||
| ZG | 246 ± 12 | 267 ± 19 | 23.06 | 7.32 to 38.79 | 0.001 | |||||||
| RTG | 231 ± 22 | 279 ± 19 | 21.85 | 6.11 to 37.59 | 0.002 | −1.21 | −16.9 to 14.5 | 1 | ||||
| ZRTG | 241 ± 23 | 282 ± 17 | 28.49 | 12.75 to 44.22 | 0.000 | 5.43 | −10.3 to 21.2 | 1 | 6.64 | −9.10 to 22.37 | 1 | |
| TAC (mmol/L) | CG | 520 ± 101 | 493 ± 77 | |||||||||
| ZG | 510 ± 79 | 562 ± 84 | 29.9 | −36.2 to 95.9 | 1 | |||||||
| RTG | 506 ± 110 | 566 ± 90 | 30.1 | −36.0 to 96.1 | 1 | 0.2 | −65.8 to 66.2 | 1 | ||||
| ZRTG | 500 ± 71 | 627 ± 52 | 57.0 | −9.0 to 123.0 | 0.133 | 27.1 | −38.9 to 93.2 | 1 | 26.9 | −39.1 to 93.0 | 1 |
Data presented as mean ± SD. MDA denotes malondialdehyde, GSH denotes glutathione, TAC denotes total antioxidant capacity.